Julie Holtzople’s Post

The #launch of a new version of the Clinical Trials Information System #CTIS is giving earlier and more efficient access to clinical trial information in Europe. #EMA #clinicaltrials #transparencyrules Revised transparency rules eliminate deferral mechanisms providing public access to approximately 4000 clinical trials.

A key change in the way patients, stakeholders and healthcare professionals access Clinical Trial Information was launched today! The Clinical Trials Information System #CTIS is another step forward for the Clinical Trial world; allowing earlier and more efficient access to information on potentially live saving clinical trials. #CTIS #Clinicaltrials #Clinicaltrialsupplies #CTS

The public consultation, the adoption of the revised CTIS transparency rules, the implementation in the system of the new features resulting in the launch of the new CTIS public portal today ! What an incredible journey leading to increased transparency for clinical trials in the EU.

🚀 Exciting News for Clinical Trials in Europe! 🚀 The revised rules for the Clinical Trials Information System (CTIS) are now in effect, enhancing access to vital clinical trial information across the EU. Patients, healthcare professionals, and stakeholders will benefit from earlier and more efficient access to data. ✅✅✅ Key Updates: ✨ Earlier Availability: Information on authorized clinical trials is now available sooner, thanks to the elimination of the deferral mechanism that delayed publication. 🔍 Increased Transparency: Approximately 4,000 clinical trials are now publicly accessible through the CTIS, with around 500 new trials added each month. 🖥️ Improved Usability: Additional features will be introduced to the CTIS portal to further enhance user experience. ✅✅✅ Benefits: 👩⚕️ Patients: Gain earlier access to crucial clinical trial information. 🏥 Clinical Trial Sponsors: Enjoy simplified processes and greater transparency. 📊 Healthcare Professionals: Access a more user-friendly system, facilitating trial enrolment and awareness of treatment options. #ClinicalTrials #Healthcare #Transparency #CTIS #EUHealthcare #ClinicalResearch #MedicalInnovation #PatientCare #ClinicalData #ResearchTransparency #HealthTech #PharmaNews #ClinicalTrialsEurope #MedicalResearch #LifeSciences #Biotech #Pharmaceuticals #HealthPolicy #PatientAdvocacy #RegulatoryAffairs #HealthInformation #CRO #AcademicResearch #HealthcareInnovation #PublicHealth #ClinicalTrialSponsors #MedicalProfessionals #HealthEconomics

BETTER CLINICAL TRIAL INFORMATION IN EUROPE The launch of a new version of the Clinical Trials Information System (CTIS) will allow earlier and more efficient access to information about clinical trials in the European Union (EU) for patients, healthcare professionals and other stakeholders. This is due to the revised transparency rules that became applicable from June 2024 in Europe. Read more: https://lnkd.in/e4F7u7Fa On OIFE's webpage you can find a list of ongoing international clinical OI-related trials in Europe: https://lnkd.in/eVzkH3-w #clinicaltrials #osteogenesisimperfecta

On International Clinical Trials Day, we want to remind sponsors that they need to act now to ensure the transition of your clinical trial to the Clinical Trial Regulation. Any clinical trial expected to be running beyond 30 January 2025 must be transitioned to the Clinical Trial Information System (#CTIS) to follow the new regulation. Start planning now! The time required to complete the authorisation can take up to three months. Watch the video ⬇ and visit 🔗 https://lnkd.in/dnUqAsp7 for more information. #ClinicalTrial

I hope this announcement finds you well. Any clinical trials conducted in the European Union(EU) must be transitioned to the Clinical Trials Information System(CTIS) by 30 January 2025. EMA has mandated that all clinical trials expected to continue beyond 30 January 2025 must transition to the Clinical Trial Information System, marking a significant step towards improved transparency and efficiency in clinical research. More attentive information can be found at the following address. https://lnkd.in/gYqtJpbS . or link to the following announcement. #clinicaltrial #CNRResearch #EMA #CTIS

A very important reminder for all those involved in clinical research ! 🔬 The transition from the CT Ditective to the Clinical Trials Regulation is instrumental to enhance the safety of subjects involved in clinical trials and facilitate multi national clinical trials across EU . Thanks in advance for proceeding with your applications through CTIS ⏱️💻🗂️👩🏻🔬👨🏽🔬 #clinicaltrials #clinicalresearch

New article now live! The start up phase of any clinical trial is critically important. Linical explains how study start up and site activation strategies can impact the direction of your clinical trial. Read more. » https://hubs.la/Q02P897D0 #clinicaltrials #clinicaldevelopment #studystartup #siteactivation #linicalCRO

Read about the Linical strategy to insuring a speedy and accurate start up phase for your clinical trial. Finding the right sites, getting them quickly activated and keeping them motivated are critical factors for the success of your trial.